NOV 15, 2018 10:30 AM PST

Cervical Cancer: Everlasting World Health Challenge

Speaker
  • President, Global Academy for Women's Health and Director at BioSciCon, Inc.
    Biography
      Dr. Olivera Markovic is a medical doctor, Ph.D in biomedical sciences, academician, cancer research scientist, entrepreneur and author. She is President of Global Academy for Women's Health and Director of BioSciCon, Inc.

      Dr. Markovic is experienced academician being elected professor/visiting/adjunct professor at six universities/medical schools: Universities in Belgrade and Skopje (Former Yugoslavia), Medical College of Pennsylvania (now Drexel University, Philadelphia, PA), Georgetown University, American University (Washington, DC), and University of Maryland Baltimore County (Baltimore, MD).

      Teaching was her vocation for 30 years, and she taught students from undergraduate, graduate, doctoral and postdoctoral level, including adult education. She taught basic medical sciences at medical schools, and science courses in colleges and universities in Washington Metro Area (Biochemistry, Biochemistry and Health, General Biology, Anatomy and Physiology, Pathophysiology, Human Body in Health and Disease, Clinical Chemistry, Biotechnology). She has long experience of reviewing the work of others, including student's projects, master and doctoral theses, scientific papers and books. Invited speaker for many national and international meetings.

      During the last two decades, her research interest has been devoted to the improvement of the methodology for early cervical cancer detection and making it available to women around the world. She and Dr. Nenad Markovic developed a new biomarker-based, IT/mobile empowered, infrastructure independent MarkPap(r) platform technology. Supported by NIH, they conducted translational research from an idea to commercial MarkPap® line of products and proposed a new strategy for fighting this disease globally. Cervical cancer is completely preventable and curable disease IF detected on time by screening.

      Dr. Markovic authored more than 200 scientific publications including books, chapters in books, invited review articles, scientific papers and patents. Author of the book "What every woman should know about cervical cancer", Springer 2008, 2010. The Second updated and extended edition was published in 2017 http://www.springer.com/biomed/cancer/book/978-1-4020-6936-9 www.amazon.com

      Global Academy for Women's Health is a non-profit organization with a mission to advance science and education in women's health globally (www.markpap.com). In August 2018, together with BioSciCon, awarded with the healthcare and pharmaceutical award Best for Women's Health Promotion Maryland by Global Health and Pharma.

    Abstract

    The main problem for insufficient cervical cancer screening globally (less than 20% women at risk) is outreach failure. Enabling POCs with modern IT/mobile technology and connecting them with remote medical centers could solve the problem.

    The Global Academy for Women's Health has studied this problem and has proposed one option for its solving this problem and its solution. The optimism for success is coming from the improved Pap test, the new MarkPap(r) test and platform technology offering a composite biomarker which provides instant evaluation of metabolic, cancerogenic and HPV effects on the specimen. It is both cytological and HPV disease testing (dual testing) in one test. It enable IT exchange of files and protocols for global networking via mobile and Internet connection between scattered POC and medical centers and with a protocol for turn-around of data within hours and timely intervention. The specimen is processed in the local POC and Images are transmitted by cell phone camera (Mobile Pap) for evaluation. Further, the presence of this biomarker allows home specimen collection and mailing the specimen to the local POC. This is a dramatic increase in the outreach for screening enabling women living in rural areas, far from medical institutions of any kind, to participate in screening. As announced, this program is aimed to start in parallel with developing local infrastructure enabling sustainability of the new developments. This is exactly according to the recommendation of WHO and dr Tadros Adhanom Ghebreyesus, Director General of WHO, who is acquainted with our work and supports our initiative.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 15, 2018 10:30 AM PST

    Cervical Cancer: Everlasting World Health Challenge


    Specialty

    Disease

    Health

    Cancer

    Hiv

    Medicine

    Biology

    Therapy

    Hpv

    Histopathology

    Behavior

    Cytology

    Sexually Transmitted Disease

    Cancer Diagnostics

    Histology

    Immunotherapy

    Geography

    North America67%

    Asia17%

    Europe17%

    Registration Source

    Website Visitors100%

    Job Title

    Facility/Department Manager67%

    Pathologist17%

    Medical Laboratory Technician17%

    Organization

    Manufacturer - Other33%

    Hospital17%

    Animal Hospital17%

    Medical Center17%

    Academic Institution17%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more